Skip to content

Clinical study of blood group genotype-matched transfusion

Clinical study of blood group genotype-matched transfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015750
Enrollment
Unknown
Registered
2018-04-18
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfusion related diseases

Interventions

Experimental group:Blood group genotype matching transfusion
Control group:Symptomatic treatment

Sponsors

Jiangsu Province Blood Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: (1) Informed consent; (2) Aged between 18 and 120.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Blood routine examination before and after blood transfusion in 24h for patients;Clinical symptoms after transfusion;Transfusion reaction;Newly-produced antibodies after transfution in 2 weeks to 3 months;

Countries

China

Contacts

Public ContactWenbiao LIANG

Jiangsu Province Blood Center

thibaut@126.com+86 18913826070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026